Total Valuation
Eastgate Biotech has a market cap or net worth of $6.77M. The enterprise value is $10.67M.
Market Cap$6.77M
Enterprise Value$10.67M
Share Statistics
Eastgate Biotech has 2,057,546,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,057,546,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Eastgate Biotech’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 63.23%.
Return on Equity (ROE)0.37
Return on Assets (ROA)-2.78
Return on Invested Capital (ROIC)63.23%
Return on Capital Employed (ROCE)0.34
Revenue Per Employee49.87K
Profits Per Employee-1.77M
Employee Count2
Asset Turnover0.08
Inventory Turnover2.26
Valuation Ratios
The current PE Ratio of Eastgate Biotech is ―. Eastgate Biotech’s PEG ratio is -0.07.
PE Ratio―
PS Ratio145.15
PB Ratio-1.50
Price to Fair Value-1.50
Price to FCF240.55
Price to Operating Cash Flow50.24
PEG Ratio-0.07
Income Statement
In the last 12 months, Eastgate Biotech had revenue of 99.73K and earned -3.54M in profits. Earnings per share was 0.00.
Revenue99.73K
Gross Profit-110.08K
Operating Income-3.27M
Pretax Income-3.54M
Net Income-3.54M
EBITDA-3.10M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.75M and capital expenditures -52.00, giving a free cash flow of -1.75M billion.
Operating Cash Flow-1.75M
Free Cash Flow-1.75M
Free Cash Flow per Share>-0.01
Dividends & Yields
Eastgate Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1467.25
52-Week Price Change0.00%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
Eastgate Biotech upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Eastgate Biotech as a current ratio of <0.01, with Debt / Equity ratio of -46.53%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.31
Net Debt to EBITDA-1.45
Interest Coverage Ratio-12.10
Taxes
In the past 12 months, Eastgate Biotech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Eastgate Biotech EV to EBITDA ratio is -6.12, with an EV/FCF ratio of 315.23.
EV to Sales190.22
EV to EBITDA-6.12
EV to Free Cash Flow315.23
EV to Operating Cash Flow166.77
Balance Sheet
Eastgate Biotech has $4.91K in cash and marketable securities with $3.08M in debt, giving a net cash position of -$3.07M billion.
Cash & Marketable Securities$4.91K
Total Debt$3.08M
Net Cash-$3.07M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is -110.37%, with operating margin of -3282.39%, and net profit margin of -3553.67%.
Gross Margin-110.37%
Operating Margin-3282.39%
Pretax Margin-3553.67%
Net Profit Margin-3553.67%
EBITDA Margin-3107.18%
EBIT Margin-3282.39%
Analyst Forecast
The average price target for Eastgate Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―